CMR substances prohibited by Omnibus Act VII
Ingredients: DIMETHYLTOLYLAMINE, TRIMETHYLBENZOYL DIPHENYLPHOSPHINE OXIDE

Date of publication: 24/06/2024

On June 24, 2024, the European Commission (EC) notified to the World Trade Organization (WTO) the “Omnibus VII” regulation. The adoption is expected to take place after the September 1st, 2025.

Background

On June 24, 2024, the European Commission (EC) notified to the World Trade Organization (WTO) the “Omnibus VII” regulation. The adoption is expected to take place after the September 1st, 2025.

This regulation incorporates substances categorized as CMR (Carcinogenic, Mutagenic, or Toxic for Reproduction) according to regulation EC 2024/197, also known as 21st Adaptation to Technical Progress (ATP) to the EU Classification, Labelling and Packaging (CLP) Regulation, into the European Cosmetic Regulation 1223/2009. Since none of these substances have been defended by the industry, they will be added to Annex II (prohibited substances) of the Cosmetics Regulation.

What’s new?

Among the newly classified CMR substances, two ingredients are used in cosmetic products:

  • Dimethyltolylamine, carcinogenic 1B – used as a nail conditioning agent
  • Trimethylbenzoyl diphenylphosphine oxide (TPO), reprotoxic 1B – used as a skin conditioning agent

What now?

Starting September 1st, 2025, products containing either of these ingredients will be banned. This means no product containing them can be available on the EU market after this date.

References

European Commission notification to the World Trade Organization (WTO). Omnibus Act VII

Linkedin Instagram Facebook

other REGULATORY UPDATES

UK Responsible Person Labelling Deadline Extension

RESPONSIBLE PERSON

Date of application: 31/12/2025

The UK Office for Product Safety and Standards (OPSS) have reviewed the requirement to label the product with the UK Responsible Person and have decided to extend this transitional provision for a total period of five years, until 31 December 2025.

Read More »

SCCS Final Opinion on the Safety of Triclocarban and Triclosan

Ingredients: TRICLOCARBAN and TRICLOSAN

Date of publication: 25/10/2022

During the plenary meeting on 24-25 October 2022, the Scientific Committee on Consumer Safety (SCCS) presented its final opinion on the safety of Triclocarban and Triclosan as substances with potential endocrine disrupting properties in cosmetic products.

Read More »
Any REGULATORY QUESTION?
E-mail

SCCS Revision of the Scientific Opinion on Vitamin A

Ingredients: RETINOL, RETINYL PALMITATE, RETINYL ACETATE, RETINYL LINOLEATE, RETINAL

Date of publication: 25/10/2022

The Scientific Committee on Consumer Safety has issued a final version of the Scientific Opinion on Vitamin A, concluding that exposure to Vitamin A derived from cosmetics can be a concern for higher exposure consumers, and since cosmetics alone do not exceed the upper limit the SCCS cannot suggest maximum concentration limits that take into account contributions from other sources.

Read More »